Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Plos One|October 27, 2021
Revisiting the Middle and Upper Palaeolithic archaeology of Gruta do Caldeirão (Tomar, Portugal)João Zilhão, Diego E Angelucci, Lee J Arnold, et al.
Gut|August 27, 2005
Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair studyL Biancone, A Orlando, A Kohn, et al.
Heliyon|December 1, 2017
Precise dating of the Middle-to-Upper Paleolithic transition in Murcia (Spain) supports late Neandertal persistence in IberiaJoão Zilhão, Daniela Anesin, Thierry Aubry, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2007
Prophylaxis and treatment of hepatitis B in immunocompromised patientsA Marzano, E Angelucci, P Andreone, et al.
Annals of Hematology|November 8, 2015
The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemiaF Efficace, G Rosti, M Breccia, et al.
Bone Marrow Transplantation|January 11, 2007
Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow TransplantationM Miano, M Labopin, O Hartmann, et al.
Leukemia|June 14, 2017
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemiaV Santini, B Allione, G Zini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) studyA Levis, A P Anselmo, A Ambrosetti, et al.
Leukemia|October 22, 2015
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patientsM A Frassanito, K De Veirman, V Desantis, et al.
Bone Marrow Transplantation|September 9, 2025
Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendationsR Greco, A Ruggeri, D P McLornan, et al.
Pageof 14